SCHEMBL5176138

SCHEMBL5176138

CS(=O)(=O)N(CCO)S(C)(=O)=O

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.38
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2640947 0.81 SMN1; SMN2 (0.33) MEN1KMT2ASMN1; SMN2
SCHEMBL7567519 0.81 KDM4E (0.36) MEN1KMT2A
SCHEMBL9682044 0.77 SMN1; SMN2 (0.39) MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5872439 0.75 MEN1 (0.35) MEN1KMT2A
SCHEMBL796093 0.74
SCHEMBL4666266 0.73 CA1 (0.48) KMT2A
SCHEMBL145294 0.73 CHRM2 (0.30)
SCHEMBL20961930 0.72
SCHEMBL2731669 0.71 TRPA1 (0.36)
SCHEMBL4613179 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1748806-A1 BIOCOMPATIBLE POLYACRYLATE COMPOSITIONS FOR MEDICAL APPLICATIONS ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2007-02-07 EP claimed
WO-2005097227-A1 BIOCOMPATIBLE POLYACRYLATE COMPOSITIONS FOR MEDICAL APPLICATIONS ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2005-10-20 WO claimed
EP-2877924-A1 DESIGN DEVELOPMENT AND IMPLEMENTATION OF ANALYZER BASED CONTROL SYSTEM AND ALGORITHM Nalco Company (US) 2015-06-03 EP disclosed
WO-2014018702-A1 DESIGN DEVELOPMENT AND IMPLEMENTATION OF ANALYZER BASED CONTROL SYSTEM AND ALGORITHM NALCO COMPANY (US) 2014-01-30 WO disclosed
WO-2011159742-A1 METHODS OF REMOVING DEPOSITS IN OIL AND GAS APPLICATIONS THE LUBRIZOL CORPORATION (US) 2011-12-22 WO disclosed
EP-1748806-A1 BIOCOMPATIBLE POLYACRYLATE COMPOSITIONS FOR MEDICAL APPLICATIONS ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2007-02-07 EP disclosed
EP-1740540-A1 PHENYL ACETAMIDES Bayer HealthCare AG (DE) 2007-01-10 EP disclosed
EP-1625153-A1 ACYLATED LYSOBACTIN-TYPE NONADEPSIPEPTIDES Bayer HealthCare AG (DE) 2006-02-15 EP disclosed
WO-2005103001-A1 PHENYL ACETAMIDES BAYER HEALTHCARE AG (DE) 2005-11-03 WO disclosed
WO-2005097227-A1 BIOCOMPATIBLE POLYACRYLATE COMPOSITIONS FOR MEDICAL APPLICATIONS ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2005-10-20 WO disclosed
EP-1583967-A2 METHOD FOR INHIBITING THE REPLICATION OF HERPES VIRUSES Bayer HealthCare AG (DE) 2005-10-12 EP disclosed
WO-2002070459-A1 NOVEL AMINO DICARBOXYLIC ACID DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2002-09-12 WO disclosed
EP-1216225-A2 NOVEL DERIVATIVES OF DICARBOXYLIC ACID HAVING PHARMACEUTICAL PROPERTIES Bayer Aktiengesellschaft (DE) 2002-06-26 EP disclosed
EP-0839034-A4 METHOD OF TREATING COLONIC ADENOMAS MERCK & CO INC (US) 2002-06-19 EP disclosed
EP-0842247-A4 DETERGENT COMPOSITIONS PROCTER & GAMBLE (US) 2001-08-16 EP disclosed
WO-2001019780-A2 NOVEL DERIVATIVES OF DICARBOXYLIC ACID HAVING PHARMACEUTICAL PROPERTIES BAYER AKTIENGESELLSCHAFT (DE) 2001-03-22 WO disclosed
EP-0842247-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-05-20 EP disclosed
EP-0839034-A1 METHOD OF TREATING COLONIC ADENOMAS Merck & Co., Inc. (US) 1998-05-06 EP disclosed
WO-1997003667-A1 METHOD OF TREATING COLONIC ADENOMAS MERCK & CO., INC. (US) 1997-02-06 WO disclosed
WO-1997003160-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-01-30 WO disclosed